424 Capital exits Reverba in strategic sale
Reverba, a patient and healthcare professional engagement provider for life sciences companies, was acquired in a strategic transaction; terms were not disclosed.
Most recent deal Thursday, November 19, 2026.
Sectors: Healthcare (1)
Follow coverage. Copy a feed link into your feed reader.
Reverba, a patient and healthcare professional engagement provider for life sciences companies, was acquired in a strategic transaction; terms were not disclosed.